Taligentherapeutics

Taligen Therapeutics is focused on the R&a;D of novel protein therapeutics for the treatment of inflammatory conditions and diseases.

Business Model:

Revenue: $10M

Employees: 2-10

Rankings

Detailed Taligentherapeutics Information

Taligentherapeutics was acquired by Alexion Pharmaceuticals.
The acquisition happend on 2011-01-31.
Details of the transaction were not public

Geographic Data

Taligentherapeutics headquarters map

Address:

City: Cambridge

State: Massachusetts

Zip:

Country: United States

Financial Info

Stage:

series b

Raised Last:

$10M

Raised Total:

$79M

Metrics

0Website Global Rank

0Website Monthly Traffic

Twitter Followers

Description

Taligen Therapeutics is focused on the discovery and development of novel protein therapeutics that modulate the alternative pathway of the complement system to treat a wide range of inflammatory conditions and diseases. The company&s;s lead therapeutic candidates are monoclonal antibodies and recombinant fusion proteins that target key factors in the alternative pathway, which Taligen&s;s founders have validated as an important amplification loop in the inflammation process.

Contact Phone:

Contact Email:

Announced Date Company Transaction Money Raised
Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research